Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.62 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.61 |
| ▸ | GSK3B | P49841 | 14/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | AAK1 | Q2M2I8 | 3/20 | 0.56 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.56 |
| ▸ | GSK3A | P49840 | 3/20 | 0.53 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.51 |
| ▸ | PIM1 | P11309 | 1/20 | 0.51 |
| ▸ | CDK2 | P24941 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4491401 | 0.88 | GSK3B (0.73) | DYRK1AGSK3BCYP1A2AAK1GSK3A | |
| SCHEMBL4491911 | 0.85 | GSK3B (0.72) | DYRK1AGSK3BCYP1A2AAK1HDAC6 | |
| SCHEMBL4494577 | 0.84 | GSK3B (0.61) | TRPA1GSK3BCYP1A2 | |
| SCHEMBL4487525 | 0.84 | GSK3B (0.73) | DYRK1AGSK3BAAK1HDAC6GSK3A | |
| SCHEMBL4499397 | 0.84 | GSK3B (0.70) | DYRK1AGSK3BAAK1HDAC6GSK3A | |
| SCHEMBL4500909 | 0.83 | HDAC6 (0.70) | DYRK1AGSK3BCYP1A2AAK1HDAC6 | |
| SCHEMBL4499351 | 0.83 | DYRK1A (0.63) | DYRK1AGSK3BCYP1A2AAK1HDAC6 | |
| SCHEMBL4497997 | 0.83 | HDAC6 (0.57) | TRPA1GSK3BCYP1A2AAK1HDAC6 | |
| SCHEMBL4491636 | 0.83 | GSK3B (0.60) | DYRK1AGSK3BCYP1A2AAK1HDAC6 | |
| SCHEMBL4489306 | 0.83 | HDAC6 (0.57) | TRPA1GSK3BCYP1A2AAK1HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7632854-B2 | Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them | PFIZER ITALIA S.R.L. (IT) | 2009-12-15 | — | — | US | claimed |